← Leaderboards
Nuria Carrillo
Brigham And Women'S Hospital
$1,656,889
Attributed
$3,313,778
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2017–20$2M$1.5M$1M$500K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$3,313,778 · 1
By mechanism
U01$3,313,778 · 1
Top collaborators
- Anthony Arnold Amato2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Robert Sackstein$20,708,410
- Elliot Israel$35,880,602
- Gerald B Pier$23,267,480
- Julie E Buring$63,823,301
- Laurie E Comstock$15,848,134
Others in their field
Other Emerging Leaders on “Mathematical Model”
- Jacob Ruff · Cornell University$14,750,000
- Elke Arenholz · Cornell University$14,750,000
- Peter John Hunter · University Of Auckland$10,288,658
- Anna Bershteyn · New York University School Of Medicine$9,111,180
- Deanna A Kulpa · Emory University$8,444,989
- Gonzalo Martin Vazquez Prokopec · Emory University$6,397,224
Research focus
Mathematical ModelAnabolismLeadMannosamineClinical TrialsBaseBiological MarkersAwarenessDisabilityCaringDisease ProgressionDouble-Blind MethodDouble-Blind Placebo Controlled TrialEnzymesCostFunctional LossDesignFutureGlycolipidsGlycoproteinsDisease ModelIn VitroIn VivoMedical
Grant awards (2)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,416,244
U01 · FY2020 · AR
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy$1,897,534
U01 · FY2017 · AR